Hughes, Andrew N.

Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers

Hughes, A. N., O'Brien, M. E. R., Petty, W. J., Chick, J. B., Rankin, E., Woll, P. J., Dunlop, D., Nicolson, M., Boinpally, R., Wolf, J., et al. (2009) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsPharmacogenetics and Drug Metabolism

Cited by 144

Association of Longitudinal Activity Measures and Diabetes Risk: An Analysis From the National Institutes of Health All of Us Research Program

Perry, A. S., Annis, J. S., Master, H., Nayor, M., Hughes, A., Kouame, A., Natarajan, K., Marginean, K., Murthy, V., Roden, D. M., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism

Physical Activity and HealthDiabetes Management and Research

Cited by 29